UBS analyst Peter Grom lowered the firm’s price target on Procter & Gamble to $161 from $176 and keeps a Buy rating on the shares. The operating environment and market backdrop for Consumer Staples remains challenging, but fundamentals could improve in 2026, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble Declares Quarterly Dividend, Extending Streak
- Halliburton, Schlumberger, SoFi, Procter, Gilead Trending
- Texas AG announces agreement with P&G on fluoride in children’s toothpaste
- Procter & Gamble price target lowered to $150 from $168 at TD Cowen
- Procter & Gamble assumed with a Neutral at Piper Sandler